¿Es candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract seguro durante el embarazo?

Related ingredients

Frequently asked questions

¿Es candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract seguro durante el embarazo?

No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR reproductive contraindications were identified for microbial/yeast ferment extracts of the listed species; peer‑reviewed literature does not indicate teratogenicity or reproductive toxicity for topical use of such ferments. Cosmetic safety databases (CosIng/EWG) commonly list these as ferment extracts without reproduction flags, consistent with CIR precedent that cosmetic ferments are 'safe as used' when appropriately processed.

¿Es candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract seguro durante la lactancia?

No evidence from regulatory sources or peer‑reviewed studies suggests systemic reproductive toxicity or secretion into breast milk from topical application of these microbial ferment extracts; no harmonised classifications or SCCS/CIR warnings were found.

¿Es candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract seguro para la piel del bebé?

Hazard and mechanism: no infant‑specific reproductive or developmental effects located. Exposure: dermal absorption from topical ferments is expected to be negligible in adults, but per guidance infant exposure scoring is increased by +1 due to higher surface‑area‑to‑weight and immature barrier, so exposure is assigned 1 for 0–3 yr skin even though systemic absorption is still expected to be low. Note: potential for topical sensitization or infection in severely immunocompromised infants is a general consideration but not a reproductive/developmental finding.

¿Cómo puntúa VeriMom a candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract?

VeriMom puntúa candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.

¿Cuáles son las alternativas seguras a candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract en el embarazo?

Consulta nuestra lista de alternativas seguras a candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract según función similar y clasificación sin riesgos conocidos.